| Bioactivity | Valsartan-d9 is deuterium labeled valsartan. Valsartan is an angiotensin II receptor antagonist and has the potential for high blood pressure and heart failure research[1]. | ||||||||||||
| Invitro | Valsartan is a synthetic non-peptide angiotensin II type 1 receptor antagonist that dilates blood vessels and reduces blood pressure by blocking the action of angiotensin. Valsartan significantly decreases the expression of AT1R in ageing aorta endothelial cells[1]. | ||||||||||||
| Name | Valsartan-d9 | ||||||||||||
| CAS | 1089736-73-1 | ||||||||||||
| Formula | C24H20D9N5O3 | ||||||||||||
| Molar Mass | 444.57 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Shan H, et al. Valsartan ameliorates ageing-induced aorta degeneration via angiotensin II type 1 receptor-mediated ERK activity. J Cell Mol Med. 2014 Jun;18(6):1071-80. |
Valsartan-d9
CAS: 1089736-73-1 F: C24H20D9N5O3 W: 444.57
Valsartan-d9 is deuterium labeled valsartan. Valsartan is an angiotensin II receptor antagonist and has the potential fo
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.